Am J Perinatol 2022; 39(06): 609-615
DOI: 10.1055/s-0040-1718369
Original Article

Suspected or Proven Early-Onset Sepsis and NLR, PLR, and MPV Parameters in Neonates with Born through MSAF

Ahmet Taşkın
1   Department of Pediatrics, Bagcilar Training and Research Hospital, Istanbul, Turkey
,
2   Neonatal Intensive Care Unit, Bagcilar Training and Research Hospital, University of Health Sciences, Istanbul, Istanbul, Turkey
,
Şahin Hamilçıkan
2   Neonatal Intensive Care Unit, Bagcilar Training and Research Hospital, University of Health Sciences, Istanbul, Istanbul, Turkey
› Author Affiliations
Funding None.

Abstract

Objective It was aimed to determine the presence of early-onset sepsis in newborns born through meconium-stained amniotic fluid (MSAF) and to investigate the changes of blood parameters in these neonates.

Study Design This cross-sectional observational study was performed with neonates born MSAF were divided into two groups as C-reactive protein (CRP) and procalcitonin (PCT) positive and negative group.

Results A total of 3,096 neonates enrolled in this study, and of these 272 with MSAF (8.7%), 76 (27.9%) with neonates were Group I and 196 (72.1%) neonates were Group II. Group I had significantly higher CRP and PCT values and monocyte values significantly lower than Group II, but there were no statistically significant differences between other investigated blood count parameters. There was no association between the platelet, mean platelet volume (MPV), plateletcrit, platelet distribution width, neutrphil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) and sepsis in neonates born MSAF. The following areas under the receiver operating characteristic curve were found, respectively: MPV was 0.49 (0.36–0.55), NLR was 0.54 (0.48–0.60), PLR was 0.53 (0.47–0.59), and MLR was 0.54 (0.48–0.60).

Conclusion MSAF might be a risk factor for early-onset sepsis in neonates. However, MPV, NLR, PLR, and MLR values cannot be helpful for the detection of suspected or proven early-onset neonatal sepsis in born MSAF neonates.

Key Points

  • MSAF might be as a risk factor for EOS in neonates.

  • CRP and procalcitonin values may help to be determined at EOS in asymtomatic neonates with MSAF.

  • MPV, NLR, PLR, andMLR values do not seemto behelpful for the early detection of sepsis inmeconium-stained term neonates.

Note

All procedures performed involving human participants follow the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards (ethical approval number: 2017–571).




Publication History

Received: 09 July 2020

Accepted: 25 August 2020

Article published online:
08 October 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Yurdakök M. Meconium aspiration syndrome: do we know?. Turk J Pediatr 2011; 53 (02) 121-129
  • 2 Whitfield JM, Charsha DS, Chiruvolu A. Prevention of meconium aspiration syndrome: an update and the Baylor experience. Proc Bayl Univ Med Cent 2009; 22 (02) 128-131
  • 3 van Ierland Y, de Boer M, de Beaufort AJ. Meconium-stained amniotic fluid: discharge vigorous newborns. Arch Dis Child Fetal Neonatal Ed 2010; 95 (01) F69-F71
  • 4 Rao S, Pavlova Z, Incerpi MH, Ramanathan R. Meconium-stained amniotic fluid and neonatal morbidity in near-term and term deliveries with acute histologic chorioamnionitis and/or funisitis. J Perinatol 2001; 21 (08) 537-540
  • 5 Mazor M, Furman B, Wiznitzer A, Shoham-Vardi I, Cohen J, Ghezzi F. Maternal and perinatal outcome of patients with preterm labor and meconium-stained amniotic fluid. Obstet Gynecol 1995; 86 (05) 830-833
  • 6 Clark P, Duff P. Inhibition of neutrophil oxidative burst and phagocytosis by meconium. Am J Obstet Gynecol 1995; 173 (04) 1301-1305
  • 7 Dirican A, Kucukzeybek BB, Alacacioglu A. et al. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?. Int J Clin Oncol 2015; 20 (01) 70-81
  • 8 Templeton AJ, McNamara MG, Šeruga B. et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014; 106 (06) dju124
  • 9 Bhat T, Teli S, Rijal J. et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013; 11 (01) 55-59
  • 10 de Jager CPC, Wever PC, Gemen EFA. et al. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One 2012; 7 (10) e46561
  • 11 Loonen AJM, de Jager CPC, Tosserams J. et al. Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit. PLoS One 2014; 9 (01) e87315
  • 12 Wu Y, Chen Y, Yang X, Chen L, Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol 2016; 36: 94-99
  • 13 Qin B, Ma N, Tang Q. et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 2016; 26 (03) 372-376
  • 14 Rifaioglu EN, Bülbül Şen B, Ekiz Ö, Cigdem Dogramaci A. Neutrophil to lymphocyte ratio in Behçet's disease as a marker of disease activity. Acta Dermatovenerol Alp Panonica Adriat 2014; 23 (04) 65-67
  • 15 Yin XN, Tang SM, Yin Y, Shen CY, Zhang B, Chen ZX. [Associations of preoperative platelet-to-lymphocyte ratio and derived neutrophil-to-lymphocyte ratio with theprognosis of gastrointestinal stromal tumor]. Sichuan Da Xue Xue Bao Yi Xue Ban 2017; 48 (02) 239-243
  • 16 Azab B, Torbey E, Singh J. et al. Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets 2011; 22 (08) 557-566
  • 17 Donnan GA, Davis SM, Parsons MW, Ma H, Dewey HM, Howells DW. How to make better use of thrombolytic therapy in acute ischemic stroke. Nat Rev Neurol 2011; 7 (07) 400-409
  • 18 Beyan C. Is mean platelet volume a predictive marker in patients with venous thrombosis?. Clin Appl Thromb Hemost 2012; 18 (06) 670-671
  • 19 Colkesen Y, Muderrisoglu H. The role of mean platelet volume in predicting thrombotic events. Clin Chem Lab Med 2012; 50 (04) 631-634
  • 20 Kelly LE, Shivananda S, Murthy P, Srinivasjois R, Shah PS. Antibiotics for neonates born through meconium-stained amniotic fluid. Cochrane Database Syst Rev 2017; 6: CD006183
  • 21 Heath JA, Zerr DM. Infections acquired in the nursery: epidemiology and control. In: Remington JS, Klein JO, Wilson CB, Baker CJ. eds. Infectious Diseases of the Fetus and Newborn Infant (ed 6). Philadelphia, PA: Elsevier Saunders; 2006: 1179-1205
  • 22 Weinberg GA, D'Angio CT. Laboratory aids for diagnosis of neonatal sepsis. In: Remington JS, Klein JO, Wilson CB, Baker CJ. eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier Saunders; 2006: 1207-1222
  • 23 Carey AJ, Saiman L, Polin RA. Hospital-acquired infections in the NICU: epidemiology for the new millennium. Clin Perinatol 2008; 35 (01) 223-249 , x
  • 24 Walsh MC, Fanaroff JM. Meconium stained fluid: approach to the mother and the baby. Clin Perinatol 2007; 34 (04) 653-665 , viii
  • 25 Shaikh EM, Mehmood S, Shaikh MA. Neonatal outcome in meconium stained amniotic fluid-one year experience. J Pak Med Assoc 2010; 60 (09) 711-714
  • 26 Escobar GJ, Li DK, Armstrong MA. et al. Neonatal sepsis workups in infants >/=2000 grams at birth: a population-based study. Pediatrics 2000; 106 (2 Pt 1): 256-263
  • 27 Blot P, Milliez J, Breart G. et al. Fetal tachycardia and meconium staining: a sign of fetal infection. Int J Gynaecol Obstet 1983; 21 (03) 189-194
  • 28 Goel A, Nangia S, Saili A, Garg A, Sharma S, Randhawa VS. Role of prophylactic antibiotics in neonates born through meconium-stained amniotic fluid (MSAF)--a randomized controlled trial. Eur J Pediatr 2015; 174 (02) 237-243
  • 29 Pongmee P, Nagar G, Campbell S, Kumar M. Antibiotic administration for prevention or treatment of meconium aspiration syndrome in neonates: a systematic review. J Clin Neonatol 2015; 4: 221-226
  • 30 Florman AL, Teubner D. Enhancement of bacterial growth in amniotic fluid by meconium. J Pediatr 1969; 74 (01) 111-114
  • 31 Bryan CS. Enhancement of bacterial infections by meconium. Johns Hopkins Med J 1967; 121: 9-13
  • 32 Schimmel M, Eidelman A, Rudensk B. Meconium stained amniotic fluid and bacterial growth a quantitative study. Pediatr Res 1996; 39: 301-302
  • 33 Pourcyrous M, Bada HS, Korones SB, Baselski V, Wong SP. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993; 92 (03) 431-435
  • 34 Vouloumanou EK, Plessa E, Karageorgopoulos DE, Mantadakis E, Falagas ME. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 2011; 37 (05) 747-762
  • 35 Mahdi M, Marodi M. B monocytes in neonatal immunity. Neoreviews 2010; 11: e558-e565
  • 36 Gioia S, Piazze J, Anceschi MM. et al. Mean platelet volume: association with adverse neonatal outcome. Platelets 2007; 18 (04) 284-288
  • 37 Oncel MY, Ozdemir R, Yurttutan S. et al. Mean platelet volume in neonatal sepsis. J Clin Lab Anal 2012; 26 (06) 493-496
  • 38 Tekin M, Konca C, Kahramaner Z. et al. The association between mean platelet volume and infants with meconium stained amniotic fluid. Eur Rev Med Pharmacol Sci 2016; 20 (14) 2983-2987
  • 39 Christensen RD, Henry E, Jopling J, Wiedmeier SE. The CBC: reference ranges for neonates. Semin Perinatol 2009; 33 (01) 3-11
  • 40 Osselaer JC, Jamart J, Scheiff JM. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem 1997; 43 (6 Pt 1): 1072-1076
  • 41 Patrick CH, Lazarchick J. The effect of bacteremia on automated platelet measurements in neonates. Am J Clin Pathol 1990; 93 (03) 391-394
  • 42 Lu Q, Duan H, Yu J, Yao Y. Are global coagulation and platelet parameters useful markers for predicting late-onset neonatal sepsis?. Clin Lab 2016; 62 (1-2): 73-79
  • 43 Chandrashekar V. Plateletcrit as a screening tool for detection of platelet quantitative disorders. J Hematol (Brossard) 2013; 2: 22-26
  • 44 Bajari R, Tak S. Predictive prognostic value of neutrophil-lymphocytes ratio in acute coronary syndrome. Indian Heart J 2017; 69 (Suppl. 01) S46-S50
  • 45 Zhang J, Zhang HY, Li J, Shao XY, Zhang CX. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and metaanalysis. Oncotarget 2017; 19: 1-10
  • 46 Xiang J, Zhou L, Li X. et al. Preoperative monocyte-to-lymphocyte ratio in peripheral blood predicts stages, metastasis, and histological grades in patients with ovarian cancer. Transl Oncol 2017; 10 (01) 33-39
  • 47 Kurtul BE, Kabatas EU, Zenciroglu A. et al. Serum neutrophil-to-lymphocyte ratio in retinopathy of prematurity. J AAPOS 2015; 19 (04) 327-331